column
    Proper Drug-selection or Just Blood Pressure Oriented in Hypertension Treatment?--Debate on the Mechanism of Action of Antihypertensive Drug
    CHEN Lu-yuan, LIN Shu-guang
    2005, 5(2): 65-67. DOI: 10.3969/j.issn.1671-5144.2005.02.001
    Abstract PDF
    The Valsartan Antihypertensive Long-term Use Evaluation Trial
    CHEN Fu-rong, ZHANG Cao-jin, LIN Qiu-wei
    2005, 5(2): 68-71. DOI: 10.3969/j.issn.1671-5144.2005.02.002
    Abstract PDF
    Intensive Lipid-lowing Therapy in Acute Coronary Syndrome(PROVE IT-TIMI 22 Study)
    LI Li-Wen, CHEN Lu-yuan
    2005, 5(2): 72-74. DOI: 10.3969/j.issn.1671-5144.2005.02.003
    Abstract PDF
    Evaluation of Valsartan, Captopril or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
    QIAN Wei-min
    2005, 5(2): 75-76. DOI: 10.3969/j.issn.1671-5144.2005.02.004
    Abstract PDF
    Invasive Versus Conservative Treatment in Unstable Coronary Syndromes
    YANG Jun-qing, CHEN Ji-yan
    2005, 5(2): 77-79. DOI: 10.3969/j.issn.1671-5144.2005.02.005
    Abstract PDF
    Placebo-controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator
    QU Yu-chun, WU Shu-lin
    2005, 5(2): 80-82. DOI: 10.3969/j.issn.1671-5144.2005.02.006
    Abstract PDF
    Prophylactic Use of an Implantable Cardioverter-defibrillator after Acute Myocardial Infarction
    CHEN Chun-bo, WU Shu-lin
    2005, 5(2): 83-84. DOI: 10.3969/j.issn.1671-5144.2005.02.007
    Abstract PDF
    A Systematic Review of Eplerenone for Essential Hypertension
    FANG Zhi-min, XU Pei-ru, XU Qin, BAO Yu-hai, LU Rui-ping
    2005, 5(2): 85-89. DOI: 10.3969/j.issn.1671-5144.2005.02.008
    Abstract PDF
    Comparison of Thrombolysis and Non-thrombolysis during Cardiopulmonary Resuscitation in Acute Myocardial Infarction: a Meta-analysis
    ZHU Zhi-Wei, MA Gang, WANG Chun-mei, SU Quan-Guan
    2005, 5(2): 90-93. DOI: 10.3969/j.issn.1671-5144.2005.02.009
    Abstract PDF
    Clinical Evidence and the Way of Thinking in Drug Interfere to Metabolic Syndromes
    ZHENG Gang
    2005, 5(2): 94-98. DOI: 10.3969/j.issn.1671-5144.2005.02.010
    Abstract PDF
    Sample-size Estimation for Survival Data Analysis
    LI He, YANG Xue-ning, WU Yi-long
    2005, 5(2): 99-102. DOI: 10.3969/j.issn.1671-5144.2005.02.011
    Abstract PDF
    Evidence-based Medicine and Principle of Good Clinical Practice in Clinical Research
    SUN Yan
    2005, 5(2): 103-109. DOI: 10.3969/j.issn.1671-5144.2005.02.012
    Abstract PDF
    Shared Decision Making
    HUA Yi-Jun, HONG Ming-Huang
    2005, 5(2): 110-112. DOI: 10.3969/j.issn.1671-5144.2005.02.013
    Abstract PDF
    NCCN Non-Hodgkin's Lymphoma Practice Guidelines(2005.1)
    LI Wen-yu
    2005, 5(2): 113-128. DOI: 10.3969/j.issn.1671-5144.2005.02.014
    Abstract PDF